Does $HIMS have a chance against $AMZN ???

I am now convinced $HIMS is so undervalued due to $AMZN launching Amazon Clinic last month nationwide in the US. I have done some research on the competitive landscape Hims is up against!

1) Amazon Healthcare offers “multiple telehealth provider groups” who each set their own rates for service. The company says

Why $BIO is dead at the bottom?

Can someone explain why BIO-RAD is still dead on the ground? This company is the only loss in my portfolio and a stain since covid era. I bought $BIO stocks from around 600, the reason behind was that their earnings was quite high and their price seemed undervalued even at the peak of covid. I refused to sell at 800 as i expected more but then it just fell and is dead on the ground for some time.

These guys produce lab equipments worldwide and demand for

Any way to access lost stocks/investments?

Someone I know previously used apps for investing (a few years back) and lost all of their information to log into them- they don’t even remember what apps were used. Is there some way for them to see what they have, such as a site that can track by using their social security number?

submitted by /u/juliaodoylie
Heart Surgery: Stocks?

Investing in heart surgery stocks or companies can be an attractive option for various reasons. Here's a list of potential factors that might make it a compelling investment:

Growing Demand: With an aging population and an increasing incidence of cardiovascular diseases, the demand for heart surgery and related medical procedures is expected to rise.

Technological Advancements: Constant innovation in medical technology can lead to breakthroughs

Why would you not buy RTX right now?

Genuinely this seems like an easy buy, but I'm sure there are logical reasons out there for RTX price to have remained suppressed. This engine issue seems overblown to me, is there a reason the problems would cost RTX so much money? Aren't their military products being used in massive quantities right now? I would love to hear y'alls thoughts. Thanks in advance!

submitted by
Recommendations with Insider Trading Info

Hey community

I'm new to investing and exploring stock screeners to help make informed choices. The abundance of options is overwhelming, so I'm seeking advice from experienced investors here.

I'm particularly interested in a screener that provides insider trading data. Both free and paid options are on the table, as long as they're reliable and user-friendly.

I appreciate a screener that’s intuitive, with a reasonable learni

Anyone else bullish on India?

India's GDP is projected to hit $10+ trillion by 2030 -- a lot of big ticket companies like Apple and Tesla are moving some of their operations to India. I know that economic growth doesn't necessarily translate to stock returns, but ETFs like SMIN are doing really well. I'm pretty bullish on India for the next decade, but wanted some input from you guys.

submitted by
WSJ Nick Timiraos - Officials are signaling that a run-up in long-term interest rates might substitute for more hikes.

Edit: Nick Timiraos is known by some on Wall Street as the "Fed Whisperer" and has at times been leaked key shifts in policy thinking at the Fed. Here is a recent article during the quiet week at the Fed leading up to September FOMC.

  • A sustained rise in long-term Treasury yields could be bringing the Federal Reserve’s histor

Medical instruments, devices and facilities pummeled today from weight-loss drugs. Overreaction?

These three sub-sectors of healthcare got pummeled today. IMO, seems like a huge over-reaction. All this because of the GLP-1 drugs? Specifically, early stop to trial of Ozempic (a positive for the drug, as efficacy has been proven early).

I can understand investor concerns relating to direct renal care companies such as Davita $DVA and $BAX, seeing a 17% and 12% drop respectively today. But why are sectors like Medical Devices (E.g. Stryker $SYK) and he

Samsung expected to report 80% profit plunge as losses mount at chip business
  • Samsung Electronics earnings are expected to plunge nearly 80% in the third quarter, according to analyst forecasts.
  • Analysts see its semiconductor business — typically Samsung’s cash cow — reporting a more than 3 trillion won ($2.2 billion) loss for the third quarter.
  • Memory chip prices have fallen dramatically this year due to a glut caused by oversupply and low demand for end products like smartphones and laptops.


Search